Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use


Product name: Gatifloxacine
Also marketed in the EU under the name(s): Bonoq, Crispin
Active substance: Gatifloxacine
Indication: Infections when due to gatifloxacin-susceptible pathogens: community-acquired pneumonia (mild to moderate) and complicated urinary tract infections (excluding prostatitis and epididymitis)
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/02/2004 Referral EMEA/H/A-31/487 (2004)614 of 20/02/2004